Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration
Ruirong Chen, Zhien Lan, Jujian Ye, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

New‐onset autoimmune phenomena post‐COVID‐19 vaccination
Yue Chen, Zhiwei Xu, Peng Wang, et al.
Immunology (2021) Vol. 165, Iss. 4, pp. 386-401
Open Access | Times Cited: 423
Therapeutic Targeting of NF-κB in Acute Lung Injury: A Double-Edged Sword
Michelle Warren Millar, Fabeha Fazal, Arshad Rahman
Cells (2022) Vol. 11, Iss. 20, pp. 3317-3317
Open Access | Times Cited: 76
The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication
Qin Ning, Di Wu, Xiaojing Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 69
Prospective Roles of Tumor Necrosis Factor-Alpha (TNF-α) in COVID-19: Prognosis, Therapeutic and Management
Zarina Mohd Zawawi, Jeevanathan Kalyanasundram, Rozainanee Mohd Zain, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6142-6142
Open Access | Times Cited: 41
Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19
Lowell Ling, Zigui Chen, Grace Lui, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 68
Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options
Yasaman Nazerian, Mobina Ghasemi, Younes Yassaghi, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109428-109428
Open Access | Times Cited: 48
Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D
Montserrat Torres, Guiomar Casado, Lorena Vigón, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 112965-112965
Open Access | Times Cited: 38
Glucocorticoids, their uses, sexual dimorphisms, and diseases: new concepts, mechanisms, and discoveries
Genesee J. Martinez, Malik Appleton, Zachary A. Kipp, et al.
Physiological Reviews (2023) Vol. 104, Iss. 1, pp. 473-532
Closed Access | Times Cited: 21
Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still’s Disease From COVID-19
Po‐Ku Chen, Joung‐Liang Lan, Po‐Hao Huang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 40
Persistent Lung Injury and Prothrombotic State in Long COVID
Mengqi Xiang, Haijiao Jing, Chengyue Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30
Circulating Levels of PD-L1, TIM-3 and MMP-7 Are Promising Biomarkers to Differentiate COVID-19 Patients That Require Invasive Mechanical Ventilation
Leslie Chávez‐Galán, Andy Ruíz, Karen Martínez‐Espinosa, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 445-445
Open Access | Times Cited: 29
Impact of cytokine storm on severity of COVID-19 disease in a private hospital in West Jakarta prior to vaccination
Diana Laila Ramatillah, Siew Hua Gan, Ika Pratiwy, et al.
PLoS ONE (2022) Vol. 17, Iss. 1, pp. e0262438-e0262438
Open Access | Times Cited: 27
Interplay of TLR4 and SARS-CoV-2: Unveiling the Complex Mechanisms of Inflammation and Severity in COVID-19 Infections
Njinju Asaba Clinton, Cyril Jabea Ekabe, Humblenoble Stembridge Ayuk, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 5077-5091
Open Access | Times Cited: 5
Autoantibodies as potential prognostic factors for clinical outcomes related to COVID-19: a systematic review of inception prospective cohort studies with GRADE recommendations
Farley Carvalho Araújo, Andre Amaral, Hytalo de Jesus Silva, et al.
Brazilian Journal of Medical and Biological Research (2025) Vol. 58
Open Access
Dissecting the COVID‐19 Immune Response: Unraveling the Pathways of Innate Sensing and Response to SARS‐CoV‐2 Structural Proteins
María Guadalupe Vizoso-Pinto, Leonardo de Paula Pereira, Ana Luiza Pessoa de Mendonça Angelo, et al.
Journal of Molecular Recognition (2025) Vol. 38, Iss. 2
Closed Access
The role of the transcription factor NF-kB in the pathogenesis of inflammation and carcinogenesis. Modulation capabilities
Maria Moneva-Sakelarieva, Yozlem Kobakova, Spiro Konstantinov, et al.
Pharmacia (2025) Vol. 72, pp. 1-13
Open Access
Alveolar Type II Cells and Pulmonary Surfactant in COVID-19 Era
Andrea Čalkovská, M Kolomazník, V. Čalkovský
Physiological Research (2021), pp. S195-S208
Open Access | Times Cited: 39
Treatments for COVID-19: Lessons from 2020 and new therapeutic options
Fanny Salasc, Thomas Lahlali, Emilie Laurent, et al.
Current Opinion in Pharmacology (2021) Vol. 62, pp. 43-59
Open Access | Times Cited: 32
Butyrate: Connecting the gut-lung axis to the management of pulmonary disorders
Renan Oliveira Corrêa, Pollyana Ribeiro Castro, René Moser, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 26
Pyronaridine Protects against SARS-CoV-2 Infection in Mouse
Ana C. Puhl, Giovanni Freitas Gomes, Samara Damasceno, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 6, pp. 1147-1160
Open Access | Times Cited: 23
Deciphering the balance of IL-6/IL-10 cytokines in severe to critical COVID-19 patients
Mouna Ben Azaiz, Awatef Ben Jemaa, Walid Sellami, et al.
Immunobiology (2022) Vol. 227, Iss. 4, pp. 152236-152236
Open Access | Times Cited: 23
Post-mortem Findings of Inflammatory Cells and the Association of 4-Hydroxynonenal with Systemic Vascular and Oxidative Stress in Lethal COVID-19
Neven Žarković, Antonia Jakovčević, Ana Mataić, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 444-444
Open Access | Times Cited: 22
Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium in vitro
Hulda R. Jónsdóttir, Denise Siegrist, Thomas Julien, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 113058-113058
Open Access | Times Cited: 22
The Dynamic Role of FOXP3+ Tregs and Their Potential Therapeutic Applications During SARS-CoV-2 Infection
Xu Zhan, Xue Jiang, Xueyu Dai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Acute coronavirus infection triggers a TNF-dependent osteoporotic phenotype in mice
Celso Martins Queiroz‐Junior, Anna Clara Paiva Menezes dos Santos, Matheus Rodrigues Gonçalves, et al.
Life Sciences (2023) Vol. 324, pp. 121750-121750
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top